Retinoic Acid Receptor Gamma (RARγ) Promotes Cartilage Destruction through Positive Feedback Activation of NF-κB Pathway in Human Osteoarthritis. (7th November 2022)
- Record Type:
- Journal Article
- Title:
- Retinoic Acid Receptor Gamma (RARγ) Promotes Cartilage Destruction through Positive Feedback Activation of NF-κB Pathway in Human Osteoarthritis. (7th November 2022)
- Main Title:
- Retinoic Acid Receptor Gamma (RARγ) Promotes Cartilage Destruction through Positive Feedback Activation of NF-κB Pathway in Human Osteoarthritis
- Authors:
- Yu, Yue-Wei
Li, Si-Yang
Zhang, Lin-Jun
Wang, Qian-Liang
Liu, Zhong-Guo
Chen, Qing-Zhi
Song, Hong-Yu
Shen, Dong-Yan
Yan, Jun - Other Names:
- Fioravanti Antonella Academic Editor.
- Abstract:
- Abstract : Osteoarthritis (OA) is a severe inflammation-related disease which leads to cartilage destruction. The retinoic acid receptor gamma (RAR γ ) has been indicated to be involved in many inflammation processes. However, the role and mechanism of RAR γ in cartilage destruction caused by inflammation in OA are still unknown. Here, we demonstrated that the RAR γ was highly expressed in chondrocytes of OA patients compared with healthy people and was positively correlated with the damage degree of cartilage in OA. Cytokine TNF- α promoted the transcription and expression of RAR γ through activating the NF- κ B pathway in OA cartilage. In addition, the overexpression of RAR γ resulted in the upregulation of matrix degradation and inflammation associated genes and downregulation of differentiation and collagen production genes in human normal chondrocyte C28/I2 cells. Mechanistically, overexpression of RAR γ could increase the level of p-I κ B α and p-P65 to regulate the expression of downstream genes. RAR γ and I κ B α also could interact with each other and had the same localization in C28/I2 cells. Moreover, the SD rats OA model induced by monosodium iodoacetate indicated that CD437 (RAR γ agonist) and TNF- α accelerated the OA progression, including more severe cartilage layer destruction, larger knee joint diameter, and higher serum ALP levels, while LY2955303 (RAR γ inhibitor) showed the opposite result. RAR γ was also highly expressed in OA group and even higher inAbstract : Osteoarthritis (OA) is a severe inflammation-related disease which leads to cartilage destruction. The retinoic acid receptor gamma (RAR γ ) has been indicated to be involved in many inflammation processes. However, the role and mechanism of RAR γ in cartilage destruction caused by inflammation in OA are still unknown. Here, we demonstrated that the RAR γ was highly expressed in chondrocytes of OA patients compared with healthy people and was positively correlated with the damage degree of cartilage in OA. Cytokine TNF- α promoted the transcription and expression of RAR γ through activating the NF- κ B pathway in OA cartilage. In addition, the overexpression of RAR γ resulted in the upregulation of matrix degradation and inflammation associated genes and downregulation of differentiation and collagen production genes in human normal chondrocyte C28/I2 cells. Mechanistically, overexpression of RAR γ could increase the level of p-I κ B α and p-P65 to regulate the expression of downstream genes. RAR γ and I κ B α also could interact with each other and had the same localization in C28/I2 cells. Moreover, the SD rats OA model induced by monosodium iodoacetate indicated that CD437 (RAR γ agonist) and TNF- α accelerated the OA progression, including more severe cartilage layer destruction, larger knee joint diameter, and higher serum ALP levels, while LY2955303 (RAR γ inhibitor) showed the opposite result. RAR γ was also highly expressed in OA group and even higher in TNF- α group. In conclusion, RAR γ /NF- κ B positive feedback loop was activated by TNF- α in chondrocyte to promote cartilage destruction. Our data not only propose a novel and precise molecular mechanism for OA disease but also provide a prospective strategy for the treatment. … (more)
- Is Part Of:
- Mediators of inflammation. Volume 2022(2022)
- Journal:
- Mediators of inflammation
- Issue:
- Volume 2022(2022)
- Issue Display:
- Volume 2022, Issue 2022 (2022)
- Year:
- 2022
- Volume:
- 2022
- Issue:
- 2022
- Issue Sort Value:
- 2022-2022-2022-0000
- Page Start:
- Page End:
- Publication Date:
- 2022-11-07
- Subjects:
- Inflammation -- Mediators -- Periodicals
Biological response modifiers -- Periodicals
Inflammation (Pathologie) -- Médiateurs
Immunomodulateurs
Biological response modifiers
Inflammation -- Mediators
Immunology
Autacoids
Immunologic Factors
Cell Adhesion Molecules
Cell Communication
Cytokines
Inflammation
Periodicals
Electronic journals
616.0473 - Journal URLs:
- https://www.hindawi.com/journals/mi/ ↗
- DOI:
- 10.1155/2022/1875736 ↗
- Languages:
- English
- ISSNs:
- 0962-9351
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library HMNTS - ELD Digital store
- Ingest File:
- 24450.xml